Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial
Kater, Arnon P, Levin, Mark-David, Dubois, Julie, Kersting, Sabina, Enggaard, Lisbeth, Veldhuis, Gerrit J, Mous, Rogier, Mellink, Clemens H M, van der Kevie-Kersemaekers, Anne-Marie F, Dobber, Johan A, Poulsen, Christian B, Frederiksen, Henrik, Janssens, Ann, Schjødt, Ida, Dompeling, Ellen C, Ranti, Juha, Brieghel, Christian, Mattsson, Mattias, Bellido, Mar, Tran, Hoa T T, Nasserinejad, Kazem, Niemann, Carsten U
Published in The lancet oncology (01.06.2022)
Published in The lancet oncology (01.06.2022)
Get full text
Journal Article
Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia
Niemann, Carsten U., Levin, Mark-David, Dubois, Julie, Kersting, Sabina, Enggaard, Lisbeth, Veldhuis, Gerrit J., Mous, Rogier, Mellink, Clemens H.M., Dobber, Johan A., Poulsen, Christian B., Frederiksen, Henrik, Janssens, Ann, Schjødt, Ida, Dompeling, Ellen C., Ranti, Juha, Mattsson, Mattias, Bellido, Mar, Tran, Hoa T.T., Nasserinejad, Kazem, Kater, Arnon P.
Published in Blood (25.02.2021)
Published in Blood (25.02.2021)
Get full text
Journal Article
Comorbidity is an independent prognostic factor in patients with advanced‐stage diffuse large B‐cell lymphoma treated with R‐CHOP: a population‐based cohort study
Wieringa, Andre, Boslooper, Karin, Hoogendoorn, Mels, Joosten, Peter, Beerden, Tim, Storm, Huib, Kibbelaar, Robby E., Veldhuis, Gerrit J., Kamp, Harmen, Rees, Bastiaan, Kluin‐Nelemans, Hanneke C., Veeger, Nic J. G. M., Roon, Eric N.
Published in British journal of haematology (01.05.2014)
Published in British journal of haematology (01.05.2014)
Get full text
Journal Article
Impact of comorbidity on health-related quality of life in newly diagnosed patients with lymphoma or multiple myeloma: results from the PROFILES-registry
Ekels, Afke, van de Poll-Franse, Lonneke V., Issa, Djamila E., Hoogendoorn, Mels, Nijziel, Marten R., Koster, Adrianus, de Jong, Cornelis N., Achouiti, Ahmed, Thielen, Noortje, Tick, Lidwine W., te Boome, Liane C. J., Bohmer, Lara H., Tiren-Verbeet, Nicolette L., Veldhuis, Gerrit J., de Boer, Fransien, van der Klift, Marjolein, Posthuma, Eduardus F. M., Oerlemans, Simone
Published in Annals of hematology (16.09.2024)
Published in Annals of hematology (16.09.2024)
Get full text
Journal Article
Ferric carboxymaltose infusion versus oral iron supplementation for preoperative iron deficiency anaemia in patients with colorectal cancer (FIT): a multicentre, open-label, randomised, controlled trial
Talboom, Kevin, Borstlap, Wernard A A, Roodbeen, Sapho X, Bruns, Emma R J, Buskens, Christianne J, Hompes, Roel, Tytgat, Kristien M A J, Tuynman, Jurriaan B, Consten, Esther C J, Heuff, Gijsbert, Kuiper, Teaco, van Geloven, Anna A W, Veldhuis, Gerrit J, van der Hoeven, Joost A B, Gerhards, Michael F, Sietses, Colin, Spinelli, Antonino, van de Ven, Anthony W H, van der Zaag, Edwin S, Westerterp, Marinke, van Westreenen, Henderik L, Dijkgraaf, Marcel L, Juffermans, Nicole P, Bemelman, Wilhelmus A
Published in The Lancet. Haematology (01.04.2023)
Published in The Lancet. Haematology (01.04.2023)
Get more information
Journal Article
Time-Limited Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) Who Have Undetectable MRD - Primary Analysis from the Randomized Phase II Vision HO141 Trial
Niemann, Carsten Utoft, Dubois, Julie, Brieghel, Christian, Kersting, Sabina, Enggaard, Lisbeth, Veldhuis, Gerrit J, Mous, Rogier, Mellink, Clemens, Dobber, Johan A, Poulsen, Christian Bjørn, Frederiksen, Henrik, Janssens, Ann, Schjødt, Ida, Dompeling, Ellen C, Ranti, Juha, Mattsson, Mattias, Bellido, Mar, Nasserinejad, Kazem, Tran, Hoa Thi Tuyet, Levin, Mark-David, Kater, Arnon P.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) - 15-Month Safety, Response and MRD Evaluation: Third Interim Analysis from the Phase II Vision HO141 Trial
Niemann, Carsten Utoft, Dubois, Julie, Kersting, Sabina, Enggaard, Lisbeth, Veldhuis, Gerrit J, Mous, Rogier, Mellink, Clemens, Dobber, Johan A, Poulsen, Christian Bjørn, Frederiksen, Henrik, Janssens, Ann, Schjødt, Ida, Dompeling, Ellen C, Ranti, Juha, Mattsson, Mattias, Bellido, Mar, Tran, Hoa T, Nasserinejad, Kazem, Levin, Mark-David, Kater, Arnon P.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Hair-removing device with a controllable laser source
CHENG XIANG S, CENSE ABRAHAM J, VELDHUIS GERRIT J, LEFKI KARIM M. T, VAN AMSTEL WILLEM D
Year of Publication 19.09.2006
Get full text
Year of Publication 19.09.2006
Patent
Hair-removing device with a controllable laser source
Lefki, Karim M. T, Cense, Abraham J, Cheng, Xiang S, Van Amstel, Willem D, Veldhuis, Gerrit J
Year of Publication 19.09.2006
Get full text
Year of Publication 19.09.2006
Patent
Skin treating device with protection against radiation pulse overdose
ROERSMA MICHIEL E, NUIJS ANTONIUS M, CENSE ABRAHAM J, VELDHUIS GERRIT J, SCHLANGEN LUCAS J.M, SIMONSEN JAN
Year of Publication 23.02.2006
Get full text
Year of Publication 23.02.2006
Patent
EINRICHTUNG ZUR HAARENTFERNUNG MIT EINER STEUERBAREN LASERQUELLE
CHENG, XIANG, S, CENSE, ABRAHAM, J, LEFKI, KARIM, M., T, VAN AMSTEL, WILLEM, D, VELDHUIS, GERRIT, J
Year of Publication 15.11.2005
Get full text
Year of Publication 15.11.2005
Patent
HAIR-REMOVING DEVICE WITH A CONTROLLABLE LASER SOURCE
CHENG, XIANG, S, CENSE, ABRAHAM, J, LEFKI, KARIM, M., T, VAN AMSTEL, WILLEM, D, VELDHUIS, GERRIT, J
Year of Publication 19.10.2005
Get full text
Year of Publication 19.10.2005
Patent
SKIN TREATING DEVICE WITH PROTECTION AGAINST RADIATION PULSE OVERDOSE
SIMONSEN, JAN, ROERSMA, MICHIEL, E, NUIJS, ANTONIUS, M, CENSE, ABRAHAM, J, SCHLANGEN, LUCAS, J., M, VELDHUIS, GERRIT, J
Year of Publication 04.02.2004
Get full text
Year of Publication 04.02.2004
Patent